The historical rank and industry rank for Shandong Keyuan Pharmaceutical Co's Days Payable or its related term are showing as below:
SZSE:301281'
s Days Payable Range Over the Past 10 Years
Min: 65.27 Med: 91.36 Max: 159.66
Current: 120.88
During the past 13 years, Shandong Keyuan Pharmaceutical Co's highest Days Payable was 159.66. The lowest was 65.27. And the median was 91.36.
SZSE:301281's Days Payable is ranked better than 66.24% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SZSE:301281: 120.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co Days Payable Chart
SZSE:301281 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Keyuan Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's Days Payable falls into.
Shandong Keyuan Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a Days Payable of 139.15 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. This is 52% above median its historical median of 91.36. Over the past decade, Shandong Keyuan Pharmaceutical Co's Days Payable has ranged from 65.27 to 159.66. According to the industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #313 out of 927 companies in the Drug Manufacturers industry, placing it in the top 33.8%.
Is Shandong Keyuan Pharmaceutical Co's Days Payable too high?
Shandong Keyuan Pharmaceutical Co's current Days Payable of 139.15 is 52% above median its 10-year median of 91.36. Over the past 10 years, this metric has ranged from a low of 65.27 to a high of 159.66. The Drug Manufacturers industry median Days Payable is 90.38. Shandong Keyuan Pharmaceutical Co's value of 139.15 is 54% above this industry median. Based on the distribution chart, Shandong Keyuan Pharmaceutical Co ranks #313 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #313 out of 927 companies for Days Payable. This puts Shandong Keyuan Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 90.38. Shandong Keyuan Pharmaceutical Co's value of 139.15 is 54% above this benchmark. Historically, Shandong Keyuan Pharmaceutical Co's own Days Payable has ranged from 65.27 to 159.66 over the past decade. While the company's 10-year median is 91.36 vs. the industry median of 90.38, Shandong Keyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Keyuan Pharmaceutical Co's current Days Payable of 139.15 is 54% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Keyuan Pharmaceutical Co's current Days Payable is 139.15, which is 52% above median its own 10-year median of 91.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.41, compared to a current price of ¥47.26 — trading 55.4% above its estimated fair value. The current Days Payable is 139.15, which is 52% above median its 10-year median of 91.36 and 54% above the Drug Manufacturers industry median of 90.38. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current Days Payable is 139.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥47.26 is trading 55.4% above its estimated GF Value™ of ¥30.41.
GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SZSE:301281:
Days Payable: 139.15 (52% above median its 10-year median of 91.36)
GF Value™: ¥30.41 vs. price of ¥47.26 (55.4% above fair value)
Industry Position: 54% above the Drug Manufacturers median (#313 of 927)
No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Keyuan Pharmaceutical Co Business Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score
Get the complete analysis for SZSE:301281
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301281 has been successfully added to your 
